Clinical Trial Detail

NCT ID NCT02439723
Title Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements no
Sponsors AHS Cancer Control Alberta
Indications

Advanced Solid Tumor

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.